The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

Table 4

The presentation of overall survival times in relation to the CD86 rs2715267 genotype in recipients.

Proportion of survivors	95%	90%	85%	75%
rs2715267	Time (months)
TT	2	3.83	5.53	18.38
TG	2.33	3.73	5.47	11.77
GG	1.43	2.3	3.5	5.07

χ²_df=3 = 17.81; ; .